US patent strengthens META’s intellectual property position in medical imaging
HALIFAX, N.S. / ACCESSWIRE / May 25, 2022 / Meta Materials Inc. (the “Company” or “META®”) (NASDAQ: MMAT), (FSE: MMAT), a developer of high performance functional materials and nanocomposites, today announced that Dr. Panos Kosmas, vice president of biomedical engineering, give a keynote lecture on Microwave imaging for medical diagnostics Thursday, May 26andas a member of 8th International Conference on Antennas and Electromagnetic Systems (AES 2022) held in Marrakech, Morocco. In his talk, Dr. Kosmas will provide an overview of his team’s R&D to develop a portable, cost-effective, and safe radio wave imaging scanner that can be used in ambulances to detect strokes, or at the hospital bedside to monitor strokes. evolution and recovery.
According to the World Stroke Organization, stroke remains the second leading cause of death and the third leading cause of combined death and disability worldwide. The estimated global cost of stroke is over US$721 billion, affecting more than 100 million people.
Point-of-care diagnostics and remote monitoring are critically dependent on data accuracy and reliability. META has developed a metamaterial technology platform to measure physiological signals with superior precision, specificity and sensitivity. META’s technology harnesses metamaterials to bend light in unordinary ways. When a film of metamaterial is placed on the skin, the signal can penetrate the tissues, improving detection accuracy. Under normal circumstances, a signal is reflected and little energy penetrates the tissues, which affects the accuracy of detection.
“The application of metamaterials in medical imaging has the potential for rapid clinical adoption, providing higher image resolution, faster scans and without the use of ionizing radiation. Our technology leads to the development of improved diagnostic tools,” said George Palikaras, President and CEO. “META has demonstrated and published the effectiveness of metamaterial technology in imaging and sensing applications. I am personally excited about how this technology will make a difference in people’s lives.
The research is the result of a collaboration between King’s College London, where Dr Kosmas previously held a full-time academic position, and META, where he is now employed full-time to lead efforts to commercialize this research. The development of the wearable scanner benefits from META’s patented “through-the-skin” metamaterial technology, which is key to detecting strokes more accurately. META’s approach has been featured in a series of peer-reviewed articles and was recently granted a US patent (US 11,246,502 B2). The system is currently under development at META’s new European R&D and sales headquarters in Athens, Greece.
“Rapid differential diagnosis of stroke is critical because the treatment window to mitigate lasting damage is short,” Dr. Kosmas said. “With our planned portable system, drugs to treat an ischemic stroke by dissolving blood clots could be administered while the patient is still in the ambulance, and in the case of a hemorrhagic stroke, preparation for surgery could begin before the patient arrives at the hospital, buying critical time in a life-or-death situation, or what medical professionals call the golden hour.
The radio wave tomography system described in META’s U.S. patent covers a wide range of potential applications, including breast imaging for cancer, brain imaging for clots, bleeding and other abnormalities, and diagnostic post-traumatic internal bleeding and/or fractures. Radio wave tomography depends on optimized evaluation algorithms, big data and powerful computers. The technique has not been sufficiently developed until recently, as the cost of hardware has decreased and sufficient computing power has become available.
About Meta Materials Inc.
META® delivers previously unattainable performance, in a range of applications, by inventing, designing, developing and manufacturing durable and highly functional materials. Our extensive technology platform enables leading global brands to deliver breakthrough products to their customers in consumer electronics, 5G communications, health and wellness, aerospace, automotive and clean energy. Our nano-optical technology provides anti-counterfeiting security features for government documents and currencies and authentication for brands. Our achievements have been widely recognized, including being named Lux Research Innovator of the Year in 2021. To learn more, visit www.metamaterial.com.
This press release contains forward-looking information or statements within the meaning of Canadian securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, relating to the Company, which may include, but are not limited to, statements regarding business strategies, product development, expansion plans and activities operations of the Company. Often, but not always, forward-looking information can be identified by the use of words such as “pursue”, “potential”, “predict”, “projects”, “seek”, “plan”, “expect”. , “intends”, “planned”, “believes” or variations (including negative variations) of these words and phrases, or statements that certain actions, events or results “might”, “could”, “should”, “would” or “would” be taken, occur or be carried out. These statements are based on the Company’s management’s current expectations and outlook of future events and are based on assumptions and subject to risks and uncertainties. Although the Company’s management believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. The forward-looking events and circumstances discussed in this release may not occur and may differ materially due to known and unknown risk factors and uncertainties affecting the Company, the capabilities of our facilities and their expansion, research and development projects of the Company, the market potential of the Company’s products, the Company’s market position, the scalability of the Company’s production capacity, the ability to engage new customers, the timing of the selection programs of materials, the ability to reduce production costs, improve metamaterials manufacturing capabilities and expand market reach into new applications and industries, the ability to accelerate time-to-market plans, the possibility of new contracts customers, the ongoing commitment of our employees, the technology industry, strategic and operational market activities and the ability management to manage and operate the business. Further details of these and other risks that may affect the Company’s business are described under the heading “Forward-Looking Information” and under the heading “Risk Factors” in the Company’s Form 10-K. filed with the SEC on March 1, 2022, with an SEC filing date of March 2, in the Company’s Form 10-Q filed with the SEC on May 10, 2022, and in subsequent filings by Meta Materials with the SEC, which are available on the SEC’s website at www.sec.gov. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in the forward-looking statements, there may be other factors that cause the actions, events or results differ from those anticipated, estimated or expected. Accordingly, readers should not place undue reliance on any forward-looking statements or information. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date they are made and the Company undertakes no obligation to publicly update or revise any forward-looking statement, whether whether as a result of new information, future events, or otherwise, except to the extent required by law.
Vice President, Corporate Development and Communications
Meta Materials Inc.
Senior Vice President
E-mail: [email protected]